Kafenac (Aceclofenac)

Aceclofenac works by reversibly blocking cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are key steps in the synthesis of prostaglandins. By lowering prostaglandin production, it diminishes inflammation, pain signaling, and fever, providing analgesic and anti‑inflammatory benefits.

The specific dose of Kafenac is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and overall health. Dosage regimens are individualized and should follow the prescriber’s instructions and local prescribing guidelines.

The safety of aceclofenac in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Kafenac, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Aceclofenac is chemically related to diclofenac but is often reported to have a slightly better gastrointestinal tolerance profile. Like other NSAIDs, it provides analgesic and anti‑inflammatory effects, but clinicians may choose it when a patient requires effective pain relief with a potentially lower risk of stomach irritation.

Kafenac tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Kafenac is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious risks include gastrointestinal ulceration or bleeding, severe liver injury, acute kidney damage, life‑threatening skin reactions such as Stevens‑Johnson syndrome, and increased cardiovascular events like heart attack or stroke. Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, jaundice, swelling, or rash.

Kafenac should be avoided in individuals with known hypersensitivity to aceclofenac or other NSAIDs, those with active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or significant liver or kidney disease. It is also contraindicated in patients taking certain anticoagulants or other NSAIDs without medical supervision.